Lidocaine IV for Postoperative Pain
Study Summary
This trial is testing whether using lidocaine to control postoperative pain may decrease the risk of postoperative delirium and other opioid-related side effects, following major reconstructive spinal surgery.
- Postoperative Pain
- Spinal Fusion
- Delirium
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
For what reasons might a doctor prescribe Lidocaine IV?
"Lidocaine IV is often used to manage cervical syndrome but it has also been effective in treating other conditions like minor burns, osteoporosis, and transplantation."
Are researchers actively seeking participants for this trial?
"That is correct, the trial is recruiting patients at the moment. The original posting date was September 17th, 2021 and the most recent update was on March 17th, 2022. They are looking for 278 individuals in total from 1 centre."
What is the FDA's position on Lidocaine given intravenously?
"Lidocaine IV received a score of 3 due to there being supportive clinical data from previous Phase 3 trials."
How many patients are receiving care through this program?
"That is correct, the posted information on clinicaltrials.gov does show that this trial is currently looking for participants. The trial was first posted on September 17th, 2021 and was last updated on March 17th, 2022. They are trying to recruit 278 patients from 1 location."
What is the efficacy of Lidocaine IV in other medical research?
"Right now, there are a total of 135 different active clinical studies investigating the use of Lidocaine IV. This includes 34 Phase 3 trials. The majority of these investigations are taking place in Calgary, Alberta. However, there are 1083 medical centres conducting research on Lidocaine IV across the globe."